Stockholders to Vote on Highly Dilutive $30M Equity Line of Credit, Posing Significant Dilution Risk
ASNS sits 16% above its 52-week low of $0.44.
Summary
Actelis Networks is seeking shareholder approval for an Equity Line of Credit (ELOC) agreement with White Lion Capital, allowing the company to sell up to $30 million in common stock, a sum significantly exceeding its current market capitalization and posing substantial dilution risk.
Key Events · Financing and Capital Events · ASNS
-
Shareholder Vote on ELOC
Stockholders will vote on authorizing the issuance of common stock under an Equity Line of Credit (ELOC) Purchase Agreement with White Lion Capital, LLC.
-
Significant Financing Potential
The ELOC allows Actelis Networks to sell up to $30 million in common stock over time, a figure substantially larger than the company's current market capitalization.
-
Immediate Commitment Shares
As consideration for the ELOC, the company has already agreed to issue 284,091 shares of common stock to White Lion.
-
Dilutive Terms
Shares under the ELOC will be sold at a discount to prevailing market prices, and the company explicitly states the issuance will have a dilutive effect on existing stockholders' economic rights and voting power.
Analysis · ASNS · Manufacturing
This Definitive Proxy Statement (DEF 14A) outlines a critical vote for Actelis Networks' future financing. The company is asking shareholders to approve the issuance of common stock under an ELOC Purchase Agreement, which could allow it to sell up to $30 million in shares to White Lion Capital. Given the company's current market capitalization of approximately $3.88 million, this facility represents a potential for extreme dilution, significantly impacting existing shareholders' ownership, voting power, and per-share value. The agreement also includes an immediate issuance of 284,091 commitment shares to White Lion. While the ELOC provides a crucial source of capital for the micro-cap company, the terms involve selling shares at a discount to market prices, and the sheer scale of potential issuance relative to the current market cap suggests a challenging path for shareholder value. Investors should be aware of the substantial dilutive effect this financing could have if fully utilized.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 43.9% of the 999 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ASNS was trading at $0.51 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $3.9M. The 52-week trading range was $0.44 to $17.80. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.